Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Holding the line
View:
Post by inventors on Jul 21, 2022 8:45am

Holding the line

Investor wallets suggest lmnl is still standing with 3 x cash compared to market price...?

False hope is to sell under false misguided variables that don't exist...lmnl still here..

Expect new data on phase I trails, there has not been ay negative surprises of late...?

There is nothing stopping lmnl in spiking...$2...$50...$110, but how realistically feasible is it without being prudent...?

Other articles have made publicly lmnl bottomed....?

Perhaps I should add one last time...?
Comment by stockbuphoon on Jul 21, 2022 9:22am
Inventors, I think you're forgetting about the huge contracts for Winnipeg plant rent/access signed for plasminogen production that they sold for nothing but hold that liability. Incredibly foolish move by managment but i guess they knew they could never get it to market themselves. I think they have about equal amount of cash as market cap after liabilities / future commitments. Good luck
Comment by Dibah420 on Jul 21, 2022 11:32am
"Perhaps I should add one last time...?" ******************************************************************************************************** Is that your final "Hail Mary?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities